CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 7,057 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00430612
NCT00430612N/ACompleted

The PACE-MI Registry Study - Outcomes of Beta-blocker Therapy After Myocardial Infarction (OBTAIN)

Northwestern University·observational·Posted Feb 2, 2007·Updated Apr 24, 2023

In Brief

An observational study for Myocardial Infarction. Completed, enrolled 7,057 participants across 23 sites in 2 countries.

Detailed Summary

The purpose of the PACE-MI (OBTAIN) registry is: * Analyze beta-blocker dose response effect on outcome over two years * Explore gender and minority differences in beta-blocker utilization and outcomes. In patients with Myocardial Infarction (MI) discharged from the hospital, beta-blocker dose will be predictive of survival. Exploratory analyses: Gender and racial effects-gender and race are, similarly, hypothesized to be predictive of post-MI survival. The existence of interactions between gender and beta-blocker effect as well as race and beta-blocker effect will also be evaluated.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesCanada, United States

Timeline

N/ACompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedFeb 2, 2007
Enrollment StartMay 1, 2009
Primary CompletionDec 1, 2013
Study CompletionOct 1, 2015
TodayJul 2, 2026
Enrollment to primary: 4.6 yearsPosted 19.4 years ago